Chuan-Chin Huang1,2, Mercedes C Becerra2, Roger Calderon3, Carmen Contreras3, Jerome Galea4, Louis Grandjean5,6,7, Leonid Lecca3, Rosa Yataco3, Zibiao Zhang1,2, Megan Murray1,2. 1. Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts. 2. Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts. 3. Partners in Health-Socios En Salud Sucursal, Lima, Peru. 4. School of Social Work, University of South Florida, Tampa, Florida. 5. Wellcome Centre for Clinical Tropical Medicine, Imperial College London, London, United Kingdom. 6. Universidad Peruana Cayetano Heredia, Lima, Peru; and. 7. TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Abstract
Rationale: The World Health Organization recommends the use of isoniazid (INH) alone or in combination with rifapentine to treat latent tuberculosis infections. The recent rise of drug-resistant tuberculosis has complicated the choice of treatment regimen for latent tuberculosis infection. Objectives: To evaluate the effects of INH preventive therapy on the contacts of patients with multidrug-resistant tuberculosis. Methods: In a prospective cohort study conducted between September 2009 and August 2012, we identified 4,500 index patients with tuberculosis and 14,044 tuberculosis-exposed household contacts who we followed for 1 year for the occurrence of incident tuberculosis disease. Although Peruvian national guidelines specify that INH preventive therapy should be provided to contacts aged 19 years old or younger, only half this group received INH preventive therapy.Measurements and Main Results: Among 4,216 contacts under 19 years of age, 2,106 contacts (50%) initiated INH preventive therapy at enrollment. The protective effect of INH was more extreme in contacts exposed to drug-sensitive tuberculosis (adjusted hazard ratio, 0.30; 95% confidence interval, 0.18-0.48) and to multidrug-resistant tuberculosis (adjusted hazard ratio, 0.19; 95% confidence interval, 0.05-0.66) compared with those exposed to mono-INH-resistant tuberculosis (adjusted hazard ratio, 0.80; 95% confidence interval, 0.23-2.80). In the second independent study, tuberculosis occurred in none of the 76 household contacts who received INH preventive therapy compared with 3% (8 of 273) of those who did not.Conclusions: Household contacts who received INH preventive therapy had a lower incidence of tuberculosis disease even when they had been exposed to an index patient with multidrug-resistant tuberculosis. INH may have a role in the management of latent multidrug-resistant tuberculosis infection.
Rationale: The World Health Organization recommends the use of isoniazid (INH) alone or in combination with rifapentine to treat latent tuberculosis infections. The recent rise of drug-resistant tuberculosis has complicated the choice of treatment regimen for latent tuberculosis infection. Objectives: To evaluate the effects of INH preventive therapy on the contacts of patients with multidrug-resistant tuberculosis. Methods: In a prospective cohort study conducted between September 2009 and August 2012, we identified 4,500 index patients with tuberculosis and 14,044 tuberculosis-exposed household contacts who we followed for 1 year for the occurrence of incident tuberculosis disease. Although Peruvian national guidelines specify that INH preventive therapy should be provided to contacts aged 19 years old or younger, only half this group received INH preventive therapy.Measurements and Main Results: Among 4,216 contacts under 19 years of age, 2,106 contacts (50%) initiated INH preventive therapy at enrollment. The protective effect of INH was more extreme in contacts exposed to drug-sensitive tuberculosis (adjusted hazard ratio, 0.30; 95% confidence interval, 0.18-0.48) and to multidrug-resistant tuberculosis (adjusted hazard ratio, 0.19; 95% confidence interval, 0.05-0.66) compared with those exposed to mono-INH-resistant tuberculosis (adjusted hazard ratio, 0.80; 95% confidence interval, 0.23-2.80). In the second independent study, tuberculosis occurred in none of the 76 household contacts who received INH preventive therapy compared with 3% (8 of 273) of those who did not.Conclusions: Household contacts who received INH preventive therapy had a lower incidence of tuberculosis disease even when they had been exposed to an index patient with multidrug-resistant tuberculosis. INH may have a role in the management of latent multidrug-resistant tuberculosis infection.
Authors: Dinesh Babu; Saifur R Khan; Nutan Srivastava; Lindsey Yeon Kyoung Suh; Andrew G Morgan; Naif Aljuhani; Richard P Fahlman; Arno G Siraki Journal: Arch Biochem Biophys Date: 2019-01-22 Impact factor: 4.013
Authors: Alimuddin Zumla; Rifat Atun; Markus Maeurer; Peter Mwaba; Zhenkun Ma; Justin O'Grady; Matthew Bates; Keertan Dheda; Michael Hoelscher; John Grange Journal: Trop Med Int Health Date: 2011-01 Impact factor: 2.622
Authors: James A Seddon; Anneke C Hesseling; Heather Finlayson; Katherine Fielding; Helen Cox; Jennifer Hughes; Peter Godfrey-Faussett; H Simon Schaaf Journal: Clin Infect Dis Date: 2013-09-24 Impact factor: 9.079
Authors: Peter J Dodd; Nyashadzaishe Mafirakureva; James A Seddon; Christopher F McQuaid Journal: Lancet Glob Health Date: 2022-05-18 Impact factor: 38.927